Edward T. Anderson - 30 Jun 2023 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Director, 10%+ Owner
Signature
/s/ Jason Cavalier, Attorney-in-Fact for Edward T. Anderson
Issuer symbol
LYRA
Transactions as of
30 Jun 2023
Net transactions value
$0
Form type
4
Filing time
05 Jul 2023, 21:46:49 UTC
Previous filing
22 Jun 2023
Next filing
19 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LYRA Stock Option Award $0 +20,000 $0.000000 20,000 30 Jun 2023 Common Stock 20,000 $4.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable on June 30, 2024, subject to the Non-Employee Director's continued service on the Board as a Non-Employee Director through such vesting date.